Filing Details

Accession Number:
0001179110-10-016142
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-16 17:08:12
Reporting Period:
2010-11-12
Filing Date:
2010-11-16
Accepted Time:
2010-11-16 17:08:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208157 T Paul Hempel 51 Sawyer Road, Suite 200
Waltham MA 02453
Sr Vp, Ld & Legal Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-12 2,000 $14.58 11,004 No 4 M Direct
Common Stock Disposition 2010-11-12 1,020 $29.22 9,984 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2010-11-12 2,000 $0.00 2,000 $14.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2001-11-21 2011-02-06 No 4 M Direct
Footnotes
  1. Includes 295 shares acquired under the Inverness Medical Innovations, Inc. Employee Stock Purchase Plan on June 30, 2010.
  2. This derivative security does not have a price.